CA2582809A1 - Replica amplification of nucleic acid arrays - Google Patents
Replica amplification of nucleic acid arrays Download PDFInfo
- Publication number
- CA2582809A1 CA2582809A1 CA002582809A CA2582809A CA2582809A1 CA 2582809 A1 CA2582809 A1 CA 2582809A1 CA 002582809 A CA002582809 A CA 002582809A CA 2582809 A CA2582809 A CA 2582809A CA 2582809 A1 CA2582809 A1 CA 2582809A1
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- features
- array
- primer
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
- B01J2219/00641—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being continuous, e.g. porous oxide substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
- B01J2219/00644—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being present in discrete locations, e.g. gel pads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00657—One-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Abstract
Disclosed are improved methods of making and using immobilized arrays of nucleic acids, particularly methods for producing replicas of such arrays. Included are methods for producing high density arrays of nucleic acids and replicas of such arrays, as well as methods for preserving the resolution of arrays through rounds of replication. Also included are methods which take advantage of the availability of replicas of arrays for increased sensitivity in detection of sequences on arrays.
Improved methods of sequencing nucleic acids immobilized on arrays utilizing single copies of arrays and methods taking further advantage of the availability of replicas of arrays are disclosed. The improvements lead to higher fidelity and longer read lengths of sequences immobilized on arrays. Methods are also disclosed which improve the efficiency of multiplex PCR
using arrays of immobilized nucleic acids.
Improved methods of sequencing nucleic acids immobilized on arrays utilizing single copies of arrays and methods taking further advantage of the availability of replicas of arrays are disclosed. The improvements lead to higher fidelity and longer read lengths of sequences immobilized on arrays. Methods are also disclosed which improve the efficiency of multiplex PCR
using arrays of immobilized nucleic acids.
Description
SEQUENCE LISTING
<110> President and Fellows of Harvard College <120> Replica Amplification of Nucleic Acid Arrays <130> 10498.87039 <140> PCT/USOO/06390 <141> 2000-03-10 <150> US 09/267,496 <151> 1999-03-12 <160> 24 <170> PatentIn Ver. 2.1 <210> 1 <211> 17 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:T7 RNA
polymerase binding sequence <400> 1 taatacgact cactata 17 <210> 2 <211> 10 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 2 tgcatgctat 10 <210> 3 <211> 25 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 3 atagcatgca atgcatttac gtagc 25 <210> 4 <211> 32 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <220>
<221> unsure <222> (27) . . (32) <223> N can be a, c, g or t <400> 4 gcagcagtac gactagcata tccgacnnnn nn 32 <210> 5 <211> 32 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <220>
<221> unsure <222> (27) . . (32) <223> N can be a, c, g or t <400> 5 cgatagcagt agcatgcagg tccgacnnnn nn 32 <210> 6 <211> 66 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 6 tcggctcatc tgcatgctgc cagcagtcgg actacgtacc ccggtacgtg cgctacacgc 60 agcttt 66 <210> 7 <211> 88 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 7 gcagcagtac gactagcata tccgacctgc gtgtagcgca cgtaccgggg tacgtagtcc 60 gactgctggc agcatgcaga tgagccga 88 <210> 8 <211> 94 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 8 cgatagcagt agcatgcagg tccgaccagc agtcggacta cgtaccccgg tacgtgcgct 60 acacgcaggt cggatatgct agtcgtactg ctgc 94 <210> 9 <211> 94 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 9 gcagcagtac gactagcata tccgacctgc gtgtagcgca cgtaccgggg tacgtagtcc 60 gactgctggt cggacctgca tgctactgct atcg 94 <210> 10 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 10 ccactacgcc tccgctttcc tctc 24 <210> 11 <211> 23 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 11 ctgccccggg ttcctcattc tct 23 <210> 12 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <220>
<221> miscfeature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <400> 12 CcactaCgcc tCCgctttCC tctc 24 <210> 13 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 13 gggcggaagc ttgaaggagg tatt 24 <210> 14 <211> 23 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 14 gcccggtctc gagcgtctgt tta 23 <210> 15 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <220>
<221> misc_feature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <400> 15 gggcggaagc ttgaaggagg tatt 24 <210> 16 <211> 47 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 16 gggcggaagc ttgaaggagg tatttaagga gaaaataccg catcagg 47 <210> 17 <211> 44 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 17 gcccggtctc gagcgtctgt ttacaccgat cgcccttccc aaca 44 <210> 18 <211> 47 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 18 gcccggtctc gagcgtctgt ttaaattcac tggccgtcgt tttacaa 47 <210> 19 <211> 45 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 19 gcccggtctc gagcgtctgt ttaccaatac gcaaaccgcc tctcc 45 <210> 20 <211> 48 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 20 ccactacgcc tccgctttcc tctcgggcgg aagcttgaag gaggtatt 48 <210> 21 <211> 46 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 21 .ctgccccggg ttcctcattc tctgcccggt ctcgagcgtc tgttta 46 <210> 22 <211> 23 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:sequencing primer <400> 22 gcccggtctc gagcgtctgt tta 23 <210> 23 <211> 60 <212> DNA
<213> Artificial Sequence <220>
<221> miscfeature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <220>
<223> Description of Artificial Sequence:sequencing template <400> 23 tcggccaacg cgcggggaga ggcggtttgc gtatcagtaa acagacgctc gagaccgggc 60 <210> 24 <211> 60 <212> DNA
<213> Artificial Sequence r = 4-<220>
<221> misc_feature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <220>
<223> Description of Artificial Sequence:sequencing template <400> 24 cccagtcacg acgttgtaaa acgacggcca gtgtcgataa acagacgctc gagaccgggc 60
<110> President and Fellows of Harvard College <120> Replica Amplification of Nucleic Acid Arrays <130> 10498.87039 <140> PCT/USOO/06390 <141> 2000-03-10 <150> US 09/267,496 <151> 1999-03-12 <160> 24 <170> PatentIn Ver. 2.1 <210> 1 <211> 17 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:T7 RNA
polymerase binding sequence <400> 1 taatacgact cactata 17 <210> 2 <211> 10 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 2 tgcatgctat 10 <210> 3 <211> 25 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 3 atagcatgca atgcatttac gtagc 25 <210> 4 <211> 32 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <220>
<221> unsure <222> (27) . . (32) <223> N can be a, c, g or t <400> 4 gcagcagtac gactagcata tccgacnnnn nn 32 <210> 5 <211> 32 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <220>
<221> unsure <222> (27) . . (32) <223> N can be a, c, g or t <400> 5 cgatagcagt agcatgcagg tccgacnnnn nn 32 <210> 6 <211> 66 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 6 tcggctcatc tgcatgctgc cagcagtcgg actacgtacc ccggtacgtg cgctacacgc 60 agcttt 66 <210> 7 <211> 88 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 7 gcagcagtac gactagcata tccgacctgc gtgtagcgca cgtaccgggg tacgtagtcc 60 gactgctggc agcatgcaga tgagccga 88 <210> 8 <211> 94 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 8 cgatagcagt agcatgcagg tccgaccagc agtcggacta cgtaccccgg tacgtgcgct 60 acacgcaggt cggatatgct agtcgtactg ctgc 94 <210> 9 <211> 94 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:hypothetical sequence <400> 9 gcagcagtac gactagcata tccgacctgc gtgtagcgca cgtaccgggg tacgtagtcc 60 gactgctggt cggacctgca tgctactgct atcg 94 <210> 10 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 10 ccactacgcc tccgctttcc tctc 24 <210> 11 <211> 23 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 11 ctgccccggg ttcctcattc tct 23 <210> 12 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <220>
<221> miscfeature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <400> 12 CcactaCgcc tCCgctttCC tctc 24 <210> 13 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 13 gggcggaagc ttgaaggagg tatt 24 <210> 14 <211> 23 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 14 gcccggtctc gagcgtctgt tta 23 <210> 15 <211> 24 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <220>
<221> misc_feature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <400> 15 gggcggaagc ttgaaggagg tatt 24 <210> 16 <211> 47 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 16 gggcggaagc ttgaaggagg tatttaagga gaaaataccg catcagg 47 <210> 17 <211> 44 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 17 gcccggtctc gagcgtctgt ttacaccgat cgcccttccc aaca 44 <210> 18 <211> 47 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 18 gcccggtctc gagcgtctgt ttaaattcac tggccgtcgt tttacaa 47 <210> 19 <211> 45 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 19 gcccggtctc gagcgtctgt ttaccaatac gcaaaccgcc tctcc 45 <210> 20 <211> 48 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 20 ccactacgcc tccgctttcc tctcgggcgg aagcttgaag gaggtatt 48 <210> 21 <211> 46 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:primer used for solid phase amplification <400> 21 .ctgccccggg ttcctcattc tctgcccggt ctcgagcgtc tgttta 46 <210> 22 <211> 23 <212> DNA
<213> Artificial Sequence <220>
<223> Description of Artificial Sequence:sequencing primer <400> 22 gcccggtctc gagcgtctgt tta 23 <210> 23 <211> 60 <212> DNA
<213> Artificial Sequence <220>
<221> miscfeature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <220>
<223> Description of Artificial Sequence:sequencing template <400> 23 tcggccaacg cgcggggaga ggcggtttgc gtatcagtaa acagacgctc gagaccgggc 60 <210> 24 <211> 60 <212> DNA
<213> Artificial Sequence r = 4-<220>
<221> misc_feature <222> (1) <223> Primer is modified to include ACRYDITE linker moiety at the 5' end <220>
<223> Description of Artificial Sequence:sequencing template <400> 24 cccagtcacg acgttgtaaa acgacggcca gtgtcgataa acagacgctc gagaccgggc 60
Claims (36)
1. A method for determining the nucleotide sequence of the features of an immobilized nucleic acid array, said method comprising the steps of:
a) ligating a first double-stranded nucleic acid probe to one end of a nucleic acid of a feature of said array, said first double stranded nucleic acid probe having a restriction endonuclease recognition site for a restriction endonuclease whose cleavage site is separate from its recognition site and which generates a protruding strand upon cleavage;
b) identifying one or more nucleotides at the end of said polynucleotide by the identity of the first double stranded nucleic acid probe ligated thereto or by extending a strand of the polynucleotide or probe;
c) amplifying the features of said array using a primer complementary to said first double stranded nucleic acid probe, such that only molecules which have been successfully ligated with said first double stranded nucleic acid probe are amplified to yield an amplified array;
d) contacting said amplified array with support such that at least a subset of nucleic acid molecules produced by said amplifying are transferred to said support;
e) covalently attaching said subset of nucleic acid molecules transferred in step (d) to said support to form a replica of said amplified array;
f) cleaving the nucleic acid features of the array with a nuclease recognizing said nuclease recognition site of said probe such that the nucleic acid of the features is shortened by one or more nucleotides; and g) repeating steps (a)-(f) until the nucleotide sequences of the features of said array are determined.
a) ligating a first double-stranded nucleic acid probe to one end of a nucleic acid of a feature of said array, said first double stranded nucleic acid probe having a restriction endonuclease recognition site for a restriction endonuclease whose cleavage site is separate from its recognition site and which generates a protruding strand upon cleavage;
b) identifying one or more nucleotides at the end of said polynucleotide by the identity of the first double stranded nucleic acid probe ligated thereto or by extending a strand of the polynucleotide or probe;
c) amplifying the features of said array using a primer complementary to said first double stranded nucleic acid probe, such that only molecules which have been successfully ligated with said first double stranded nucleic acid probe are amplified to yield an amplified array;
d) contacting said amplified array with support such that at least a subset of nucleic acid molecules produced by said amplifying are transferred to said support;
e) covalently attaching said subset of nucleic acid molecules transferred in step (d) to said support to form a replica of said amplified array;
f) cleaving the nucleic acid features of the array with a nuclease recognizing said nuclease recognition site of said probe such that the nucleic acid of the features is shortened by one or more nucleotides; and g) repeating steps (a)-(f) until the nucleotide sequences of the features of said array are determined.
2. The method of claim 1 wherein said nucleic acid probe comprises four components, each component being capable of indicating the presence of a different nucleotide in said protruding strand upon ligation.
3. The method of claim 2 wherein each of said components of said probe is labeled with a different fluorescent dye and the different fluorescent dyes are spectrally resolvable.
4. The method of claim 1 wherein after said step (e) and before said step (f), the features of said array are amplified.
5. The method of claim 1 wherein amplification is performed by PCR.
6. The method of claim 1 wherein:
i) after one or more cycles using said first double stranded nucleic acid probe in step (a), a distinct nucleic acid probe is used, in place of said first double stranded nucleic probe in step (a), said distinct nucleic acid probe comprising a restriction endonuclease recognition site for a restriction endonuclease whose cleavage site is separated from its recognition site, said distinct nucleic acid probe also comprising sequences such that a primer complementary to said distinct nucleic acid probe will not hybridize with said first double stranded nucleic acid probe; and ii) a primer complementary to said distinct nucleic acid probe is used in place of said primer complementary to said first double stranded nucleic acid probe in step (c), so that selective amplification of those features which successfully completed the previous cycle of restriction and ligation occurs.
i) after one or more cycles using said first double stranded nucleic acid probe in step (a), a distinct nucleic acid probe is used, in place of said first double stranded nucleic probe in step (a), said distinct nucleic acid probe comprising a restriction endonuclease recognition site for a restriction endonuclease whose cleavage site is separated from its recognition site, said distinct nucleic acid probe also comprising sequences such that a primer complementary to said distinct nucleic acid probe will not hybridize with said first double stranded nucleic acid probe; and ii) a primer complementary to said distinct nucleic acid probe is used in place of said primer complementary to said first double stranded nucleic acid probe in step (c), so that selective amplification of those features which successfully completed the previous cycle of restriction and ligation occurs.
7. The method of claim 6 wherein a new distinct nucleic acid probe is used after each cycle of restriction and ligation, said new distinct nucleic acid probe comprising a sequence such that a primer complementary to that sequence will not hybridize to any probe used in previous cycles.
8. A method of determining the nucleotide sequence of the features of an array of immobilized nucleic acids comprising the steps of:
a) adding a mixture comprising an oligonucleotide primer and a template-dependent polymerase to an array of immobilized nucleic acid features under conditions permitting hybridization of the primer to the immobilized nucleic acids;
b) adding a single, fluorescently labeled deoxynucleoside triphosphate to the mixture under conditions which permit incorporation of the labeled deoxynucleotide onto the 3' end of the primer if it is complementary to the next adjacent base in the sequence to be determined;
c) detecting incorporated label by monitoring fluorescence;
d) repeating steps (b)-(c) with each of the remaining three labeled deoxynucleoside triphosphates in turn; and e) repeating steps (b)-(d) until the nucleotide sequence is determined.
a) adding a mixture comprising an oligonucleotide primer and a template-dependent polymerase to an array of immobilized nucleic acid features under conditions permitting hybridization of the primer to the immobilized nucleic acids;
b) adding a single, fluorescently labeled deoxynucleoside triphosphate to the mixture under conditions which permit incorporation of the labeled deoxynucleotide onto the 3' end of the primer if it is complementary to the next adjacent base in the sequence to be determined;
c) detecting incorporated label by monitoring fluorescence;
d) repeating steps (b)-(c) with each of the remaining three labeled deoxynucleoside triphosphates in turn; and e) repeating steps (b)-(d) until the nucleotide sequence is determined.
9. The method of claim 8 wherein the primer, buffer and polymerase are cast into a polyacrylamide gel bearing the array of immobilized nucleic acids.
10. The method of claim 9 wherein said polyacrylamide gel is macroporous.
11. The method of claim 10 wherein said polyacrylamide gel comprises up to about 25% PEG, about 3% to about 12%
total acrylamide and about 1% to about 30% cross linker.
total acrylamide and about 1% to about 30% cross linker.
12. The method of claim 11 wherein the percentage of said PEG is about 2.5%.
13. The method of claim 10 wherein said polyacrylamide gel comprises DATD.
14. The method of claim 8 wherein single-stranded binding protein is present during step (b).
15. The method of claim 8 wherein said single fluorescently labeled deoxynucleotide further comprises a mixture of the single deoxynucleoside triphosphate in labeled and unlabeled forms.
16. The method of claim 8 wherein after step (d) and before step (e) the additional step of photobleaching said array is performed.
17. The method of claim 8 wherein said fluorescently labeled deoxynucleoside triphosphates are labeled with a cleavable linkage to the fluorophore.
18. The method of claim 17 wherein after step (d) and before step (e) the additional step of cleaving said linkage to the fluorophore is performed.
19. The method of claim 18 wherein said step of cleaving comprises contacting said linkage with a reducing agent.
20. The method of claim 19 wherein said reducing agent is dithiothreitol.
21. The method of claim 8 wherein said oligonucleotide primer comprises sequences permitting formation of a hairpin loop.
22. The method of claim 8 wherein after a predetermined number of cycles of steps (b)-(d), a defined regimen of deoxynucleotide and chain-terminating deoxynucleotide analog addition is performed, such that out-of-phase molecules are blocked from further extension cycles, said regimen followed by continued cycles of steps (b)-(d) until said nucleotide sequence is determined.
23. A method of determining the nucleotide sequence of the features of an array of immobilized nucleic acids comprising the steps of:
a) adding a mixture comprising an oligonucleotide primer and a template-dependent polymerase to an array of immobilized nucleic acid features under conditions permitting hybridization of the primer to the immobilized nucleic acids;
b) adding a first mixture of three unlabeled deoxynucleoside triphosphates under conditions which permit incorporation of deoxynucleotides to the end of the primer if they are complementary to the next adjacent base in the sequence to be determined;
c) adding a second mixture of three unlabeled deoxynucleoside triphosphates, said second mixture comprising the deoxynucleoside triphosphate not included in the mixture of step (b), under conditions which permit incorporation of deoxynucleotides to the end of the primer if they are complementary to the next adjacent base in the sequence to be determined;
d) repeating steps (b)-(c) for a predetermined number of cycles;
e) adding a single, fluorescently labeled deoxynucleoside triphosphate to the mixture under conditions which permit incorporation of the labeled deoxynucleotide onto the 3' terminus of the primer if it is complementary to the next adjacent base in the sequence to be determined;
f) detecting incorporated label by monitoring fluorescence;
g) repeating steps (e)-(f), with each of the remaining three labeled deoxynucleoside triphosphates in turn; and h) repeating steps (e)-(g) until the nucleotide sequence is determined.
a) adding a mixture comprising an oligonucleotide primer and a template-dependent polymerase to an array of immobilized nucleic acid features under conditions permitting hybridization of the primer to the immobilized nucleic acids;
b) adding a first mixture of three unlabeled deoxynucleoside triphosphates under conditions which permit incorporation of deoxynucleotides to the end of the primer if they are complementary to the next adjacent base in the sequence to be determined;
c) adding a second mixture of three unlabeled deoxynucleoside triphosphates, said second mixture comprising the deoxynucleoside triphosphate not included in the mixture of step (b), under conditions which permit incorporation of deoxynucleotides to the end of the primer if they are complementary to the next adjacent base in the sequence to be determined;
d) repeating steps (b)-(c) for a predetermined number of cycles;
e) adding a single, fluorescently labeled deoxynucleoside triphosphate to the mixture under conditions which permit incorporation of the labeled deoxynucleotide onto the 3' terminus of the primer if it is complementary to the next adjacent base in the sequence to be determined;
f) detecting incorporated label by monitoring fluorescence;
g) repeating steps (e)-(f), with each of the remaining three labeled deoxynucleoside triphosphates in turn; and h) repeating steps (e)-(g) until the nucleotide sequence is determined.
24. The method of claim 23 wherein for said first or second mixtures of three unlabeled deoxynucleoside triphosphates, a mixture which comprises deoxyguanosine triphosphate further comprises deoxyadenosine triphosphate.
25. The method of claim 23 wherein the primer and polymerase are cast into a polyacrylamide gel bearing the array of immobilized nucleic acids.
26. The method of claim 23 wherein said single fluorescently labeled deoxynucleotide further comprises a mixture of the single deoxynucleoside triphosphate in labeled and unlabeled forms.
27. The method of claim 23 wherein after step (g) and before step (h) the additional step of photobleaching said array is performed.
28. The method of claim 23 wherein said fluorescently labeled deoxynucleoside triphosphates are labeled with a cleavable linkage to the fluorophore.
29. The method of claim 28 wherein after step (g) and before step (h) the additional step of cleaving said linkage to the fluorophore is performed.
30. The method of claim 23 wherein said oligonucleotide primer comprises sequences permitting formation of a hairpin loop.
31. The method of claim 23 wherein after a predetermined number of cycles of steps (e)-(g), a defined regimen of deoxynucleotide and chain-terminating deoxynucleotide analog addition is performed, such that out-of-phase molecules are blocked from further extension cycles, said regimen followed by continued cycles of steps (e)-(g) until said nucleotide sequence of the features of the array is determined.
32. A method of determining the nucleotide sequence of the features of a microarray of nucleic acid molecules, said method comprising the following steps:
a) creating a microarray of nucleic acid features in a linear arrangement within and along one side of a polyacrylamide gel, said gel further comprising one or more oligonucleotide primers, and a template-dependent polymerizing activity;
b) amplifying the microarray of step (a);
c) adding a mixture of deoxynucleoside triphosphates, said mixture comprising each of the four deoxynucleoside triphosphates dATP, dGTP, dCTP and dTTP, said mixture further comprising chain-terminating analogs of each of the deoxynucleoside triphosphates dATP, dGTP, dCTP
and dTTP, and said chain-terminating analogs each distinguishably labeled with a spectrally distinguishable fluorescent moiety;
d) incubating said mixture with said microarray under conditions permitting extension of said one or more oligonucleotide primers;
e) electrophoretically separating the products of said extension within said polyacrylamide gel; and f) determining the nucleotide sequence of the features of said microarray by detecting the fluorescence of the extended, terminated and separated reaction products within the gel.
a) creating a microarray of nucleic acid features in a linear arrangement within and along one side of a polyacrylamide gel, said gel further comprising one or more oligonucleotide primers, and a template-dependent polymerizing activity;
b) amplifying the microarray of step (a);
c) adding a mixture of deoxynucleoside triphosphates, said mixture comprising each of the four deoxynucleoside triphosphates dATP, dGTP, dCTP and dTTP, said mixture further comprising chain-terminating analogs of each of the deoxynucleoside triphosphates dATP, dGTP, dCTP
and dTTP, and said chain-terminating analogs each distinguishably labeled with a spectrally distinguishable fluorescent moiety;
d) incubating said mixture with said microarray under conditions permitting extension of said one or more oligonucleotide primers;
e) electrophoretically separating the products of said extension within said polyacrylamide gel; and f) determining the nucleotide sequence of the features of said microarray by detecting the fluorescence of the extended, terminated and separated reaction products within the gel.
33. The method of claim 32 wherein said amplifying is performed by PCR.
34. The method of claim 32 wherein said amplifying is performed by an isothermal method.
35. The method of claim 32 wherein said microarray of nucleic acid features in a linear arrangement is derived as a replica of features arranged on a chromosome.
36. The method of claim 32 wherein said microarray of nucleic acid features in a linear arrangement is derived as a replica of one linear subset of features on a separate, non-linear microarray of nucleic acid features.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/267,496 | 1999-03-12 | ||
US09/267,496 US6485944B1 (en) | 1997-10-10 | 1999-03-12 | Replica amplification of nucleic acid arrays |
CA002370535A CA2370535C (en) | 1999-03-12 | 2000-03-10 | Replica amplification of nucleic acid arrays |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002370535A Division CA2370535C (en) | 1999-03-12 | 2000-03-10 | Replica amplification of nucleic acid arrays |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2582809A1 true CA2582809A1 (en) | 2000-09-14 |
Family
ID=23019033
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002582809A Abandoned CA2582809A1 (en) | 1999-03-12 | 2000-03-10 | Replica amplification of nucleic acid arrays |
CA002370535A Expired - Lifetime CA2370535C (en) | 1999-03-12 | 2000-03-10 | Replica amplification of nucleic acid arrays |
CA002411514A Abandoned CA2411514A1 (en) | 1999-03-12 | 2000-03-10 | Nucleotide compounds having a cleavable linker |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002370535A Expired - Lifetime CA2370535C (en) | 1999-03-12 | 2000-03-10 | Replica amplification of nucleic acid arrays |
CA002411514A Abandoned CA2411514A1 (en) | 1999-03-12 | 2000-03-10 | Nucleotide compounds having a cleavable linker |
Country Status (6)
Country | Link |
---|---|
US (3) | US6485944B1 (en) |
EP (2) | EP1235929A2 (en) |
JP (1) | JP2003526331A (en) |
AU (1) | AU3876100A (en) |
CA (3) | CA2582809A1 (en) |
WO (1) | WO2000053812A2 (en) |
Families Citing this family (325)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2281205A1 (en) | 1997-02-12 | 1998-08-13 | Eugene Y. Chan | Methods and products for analyzing polymers |
US6893877B2 (en) | 1998-01-12 | 2005-05-17 | Massachusetts Institute Of Technology | Methods for screening substances in a microwell array |
US7875440B2 (en) | 1998-05-01 | 2011-01-25 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6780591B2 (en) | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
CA2367912A1 (en) | 1999-03-19 | 2000-09-28 | Genencor International, Inc. | Multi-through hole testing plate for high throughput screening |
US7056661B2 (en) | 1999-05-19 | 2006-06-06 | Cornell Research Foundation, Inc. | Method for sequencing nucleic acid molecules |
US8137906B2 (en) * | 1999-06-07 | 2012-03-20 | Sloning Biotechnology Gmbh | Method for the synthesis of DNA fragments |
US20020151040A1 (en) | 2000-02-18 | 2002-10-17 | Matthew O' Keefe | Apparatus and methods for parallel processing of microvolume liquid reactions |
GB2360282A (en) * | 2000-03-17 | 2001-09-19 | Bioinvent Int Ab | Making and using micro-arrays of biological materials |
US7846733B2 (en) | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
EP3034627B1 (en) | 2000-10-06 | 2019-01-30 | The Trustees of Columbia University in the City of New York | Massive parallel method for decoding dna and rna |
US9708358B2 (en) | 2000-10-06 | 2017-07-18 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding DNA and RNA |
CA2426509A1 (en) * | 2000-10-23 | 2002-05-16 | Ingeny Holding Bv | Method and device for detecting a mutation in a nucleic acid fragment in a sample |
WO2002044425A2 (en) | 2000-12-01 | 2002-06-06 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
US6858413B2 (en) | 2000-12-13 | 2005-02-22 | Nugen Technologies, Inc. | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
AU2002233540A1 (en) * | 2001-02-23 | 2002-09-12 | Pyrosequencing Ab | Allele-specific primer extension assay |
MXPA02012739A (en) | 2001-03-09 | 2004-04-20 | Nugen Technologies Inc | Methods and compositions for amplification of rna sequences. |
US20040161741A1 (en) | 2001-06-30 | 2004-08-19 | Elazar Rabani | Novel compositions and processes for analyte detection, quantification and amplification |
US9777312B2 (en) * | 2001-06-30 | 2017-10-03 | Enzo Life Sciences, Inc. | Dual polarity analysis of nucleic acids |
US9261460B2 (en) | 2002-03-12 | 2016-02-16 | Enzo Life Sciences, Inc. | Real-time nucleic acid detection processes and compositions |
US7668697B2 (en) | 2006-02-06 | 2010-02-23 | Andrei Volkov | Method for analyzing dynamic detectable events at the single molecule level |
AU2002354577B2 (en) | 2001-07-13 | 2007-02-08 | Ambergen, Inc. | Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
ATE414767T1 (en) * | 2001-11-22 | 2008-12-15 | Sloning Biotechnology Gmbh | NUCLEIC ACID LINKERS AND THEIR USE IN GENE SYNTHESIS |
GB0129012D0 (en) | 2001-12-04 | 2002-01-23 | Solexa Ltd | Labelled nucleotides |
US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
CA2481495C (en) * | 2002-04-04 | 2011-08-30 | Biotage Ab | Primer extension based method employing nucleotides labelled via cleavable linkers |
US7452712B2 (en) | 2002-07-30 | 2008-11-18 | Applied Biosystems Inc. | Sample block apparatus and method of maintaining a microcard on a sample block |
ES2694651T3 (en) | 2002-08-23 | 2018-12-26 | Illumina Cambridge Limited | Labeled nucleotides |
EP1530578B1 (en) | 2002-08-23 | 2013-03-13 | Illumina Cambridge Limited | Modified nucleotides for polynucleotide sequencing |
US11008359B2 (en) | 2002-08-23 | 2021-05-18 | Illumina Cambridge Limited | Labelled nucleotides |
US7414116B2 (en) | 2002-08-23 | 2008-08-19 | Illumina Cambridge Limited | Labelled nucleotides |
US8277753B2 (en) | 2002-08-23 | 2012-10-02 | Life Technologies Corporation | Microfluidic transfer pin |
WO2004029294A1 (en) * | 2002-09-27 | 2004-04-08 | Biotage Ab | New sequencing method for sequencing rna molecules |
JP4329322B2 (en) * | 2002-10-04 | 2009-09-09 | ソニー株式会社 | INTERACTIVE ACTION DETECTION METHOD, BIO ASSAY DEVICE, AND BIO ASSY |
CA2507189C (en) | 2002-11-27 | 2018-06-12 | Sequenom, Inc. | Fragmentation-based methods and systems for sequence variation detection and discovery |
EP2031070B1 (en) | 2002-12-04 | 2013-07-17 | Life Technologies Corporation | Multiplex amplification of polynucleotides |
US7682565B2 (en) | 2002-12-20 | 2010-03-23 | Biotrove, Inc. | Assay apparatus and method using microfluidic arrays |
CA2521084A1 (en) | 2003-04-14 | 2004-10-28 | Nugen Technologies, Inc. | Global amplification using a randomly primed composite primer |
DE602004018631D1 (en) | 2003-04-24 | 2009-02-05 | Afshin Ahmadian | EN |
US20050039420A1 (en) * | 2003-07-31 | 2005-02-24 | Albritton Charles Wade | Fluid sensing in a drip tray |
WO2005024068A2 (en) | 2003-09-05 | 2005-03-17 | Sequenom, Inc. | Allele-specific sequence variation analysis |
US20050112634A1 (en) * | 2003-09-19 | 2005-05-26 | Woudenberg Timothy M. | High density sequence detection methods and apparatus |
US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
WO2005063787A2 (en) * | 2003-12-23 | 2005-07-14 | Applera Corporation | Propargyl substituted nucleoside compounds and methods |
EP3175914A1 (en) | 2004-01-07 | 2017-06-07 | Illumina Cambridge Limited | Improvements in or relating to molecular arrays |
DE602004029326D1 (en) * | 2004-01-23 | 2010-11-11 | Sloning Biotechnology Gmbh | Enzymatic production of nucleic acid molecules |
WO2005080605A2 (en) | 2004-02-19 | 2005-09-01 | Helicos Biosciences Corporation | Methods and kits for analyzing polynucleotide sequences |
EP2208797A3 (en) | 2004-03-01 | 2010-11-24 | Applied Biosystems, LLC | Methods, compositions and kits for use in polynucleotide amplification |
CA2559171A1 (en) | 2004-03-12 | 2005-09-29 | Biotrove, Inc. | Nanoliter array loading |
GB2413796B (en) * | 2004-03-25 | 2006-03-29 | Global Genomics Ab | Methods and means for nucleic acid sequencing |
CA2561381C (en) | 2004-03-26 | 2015-05-12 | Sequenom, Inc. | Base specific cleavage of methylation-specific amplification products in combination with mass analysis |
US20050255485A1 (en) * | 2004-05-14 | 2005-11-17 | Livak Kenneth J | Detection of gene duplications |
US20060030037A1 (en) | 2004-05-28 | 2006-02-09 | Victor Joseph | Thermo-controllable high-density chips for multiplex analyses |
US7692219B1 (en) | 2004-06-25 | 2010-04-06 | University Of Hawaii | Ultrasensitive biosensors |
WO2006031745A2 (en) * | 2004-09-10 | 2006-03-23 | Sequenom, Inc. | Methods for long-range sequence analysis of nucleic acids |
US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
GB2423819B (en) * | 2004-09-17 | 2008-02-06 | Pacific Biosciences California | Apparatus and method for analysis of molecules |
US7785785B2 (en) | 2004-11-12 | 2010-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
KR100766750B1 (en) * | 2004-12-13 | 2007-10-17 | 주식회사 엘지생명과학 | Method for fabricating a biochip |
WO2006099579A2 (en) * | 2005-03-16 | 2006-09-21 | Applera Corporation | Compositions and methods for clonal amplification and analysis of polynucleotides |
US20060228721A1 (en) | 2005-04-12 | 2006-10-12 | Leamon John H | Methods for determining sequence variants using ultra-deep sequencing |
CA2611671C (en) | 2005-06-15 | 2013-10-08 | Callida Genomics, Inc. | Single molecule arrays for genetic and chemical analysis |
GB0517097D0 (en) | 2005-08-19 | 2005-09-28 | Solexa Ltd | Modified nucleosides and nucleotides and uses thereof |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
WO2007030759A2 (en) | 2005-09-07 | 2007-03-15 | Nugen Technologies, Inc. | Improved nucleic acid amplification procedure |
GB2446084B (en) | 2005-10-31 | 2011-03-02 | Univ Columbia | Synthesis of four color 3-o-allyl modified photocleavable fluorescent nucleotides and related methods |
US8796432B2 (en) | 2005-10-31 | 2014-08-05 | The Trustees Of Columbia University In The City Of New York | Chemically cleavable 3'-o-allyl-DNTP-allyl-fluorophore fluorescent nucleotide analogues and related methods |
WO2007120208A2 (en) * | 2005-11-14 | 2007-10-25 | President And Fellows Of Harvard College | Nanogrid rolling circle dna sequencing |
US20080272006A1 (en) * | 2005-11-30 | 2008-11-06 | Zhiqiang Gao | Electrochemical Method of Detecting an Analyte |
US20070172839A1 (en) * | 2006-01-24 | 2007-07-26 | Smith Douglas R | Asymmetrical adapters and methods of use thereof |
WO2007092538A2 (en) * | 2006-02-07 | 2007-08-16 | President And Fellows Of Harvard College | Methods for making nucleotide probes for sequencing and synthesis |
US20070231823A1 (en) | 2006-03-23 | 2007-10-04 | Mckernan Kevin J | Directed enrichment of genomic DNA for high-throughput sequencing |
RU2394915C2 (en) * | 2006-03-24 | 2010-07-20 | Александр Борисович Четверин | Non-contact methods of detecting molecular colonies, sets of reagents and device for realising said methods |
US8399188B2 (en) | 2006-09-28 | 2013-03-19 | Illumina, Inc. | Compositions and methods for nucleotide sequencing |
EP2548647B1 (en) * | 2006-10-20 | 2018-08-15 | CLONDIAG GmbH | Assay devices and methods for the detection of analytes |
WO2008070352A2 (en) | 2006-10-27 | 2008-06-12 | Complete Genomics, Inc. | Efficient arrays of amplified polynucleotides |
WO2008069973A2 (en) | 2006-12-01 | 2008-06-12 | The Trustees Of Columbia University In The City Of New York | Four-color dna sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
US11339430B2 (en) | 2007-07-10 | 2022-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US8349167B2 (en) | 2006-12-14 | 2013-01-08 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
JP5622392B2 (en) | 2006-12-14 | 2014-11-12 | ライフ テクノロジーズ コーポレーション | Method and apparatus for analyte measurement using large-scale FET arrays |
US8262900B2 (en) | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US7932034B2 (en) * | 2006-12-20 | 2011-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Heat and pH measurement for sequencing of DNA |
US11035823B2 (en) | 2009-03-17 | 2021-06-15 | Qiagen Sciences, Llc | Methods and devices for sequencing nucleic acids in smaller batches |
US8481259B2 (en) | 2007-02-05 | 2013-07-09 | Intelligent Bio-Systems, Inc. | Methods and devices for sequencing nucleic acids in smaller batches |
US11940413B2 (en) | 2007-02-05 | 2024-03-26 | IsoPlexis Corporation | Methods and devices for sequencing nucleic acids in smaller batches |
US9029085B2 (en) | 2007-03-07 | 2015-05-12 | President And Fellows Of Harvard College | Assays and other reactions involving droplets |
WO2008157640A2 (en) | 2007-06-18 | 2008-12-24 | Illumina, Inc. | Microfabrication methods for the optimal patterning of substrates |
US20090068170A1 (en) * | 2007-07-13 | 2009-03-12 | President And Fellows Of Harvard College | Droplet-based selection |
US20110014611A1 (en) | 2007-10-19 | 2011-01-20 | Jingyue Ju | Design and synthesis of cleavable fluorescent nucleotides as reversible terminators for dna sequences by synthesis |
US9115163B2 (en) | 2007-10-19 | 2015-08-25 | The Trustees Of Columbia University In The City Of New York | DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators |
JP5738597B2 (en) | 2007-12-21 | 2015-06-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Systems and methods for nucleic acid sequencing |
US8034568B2 (en) | 2008-02-12 | 2011-10-11 | Nugen Technologies, Inc. | Isothermal nucleic acid amplification methods and compositions |
US20090215050A1 (en) * | 2008-02-22 | 2009-08-27 | Robert Delmar Jenison | Systems and methods for point-of-care amplification and detection of polynucleotides |
US9017973B2 (en) | 2008-03-19 | 2015-04-28 | Intelligent Biosystems, Inc. | Methods and compositions for incorporating nucleotides |
US7846666B2 (en) * | 2008-03-21 | 2010-12-07 | Nugen Technologies, Inc. | Methods of RNA amplification in the presence of DNA |
BRPI0909212A2 (en) | 2008-03-28 | 2015-08-18 | Pacific Biosciences California | Compositions and method for nucleic acid sequencing |
US9115352B2 (en) * | 2008-03-31 | 2015-08-25 | Sloning Biotechnology Gmbh | Method for the preparation of a nucleic acid library |
WO2010008480A2 (en) | 2008-06-25 | 2010-01-21 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes using large scale fet arrays |
US8198028B2 (en) | 2008-07-02 | 2012-06-12 | Illumina Cambridge Limited | Using populations of beads for the fabrication of arrays on surfaces |
WO2010033200A2 (en) | 2008-09-19 | 2010-03-25 | President And Fellows Of Harvard College | Creation of libraries of droplets and related species |
US20100301398A1 (en) | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US20100137143A1 (en) | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US8748094B2 (en) | 2008-12-19 | 2014-06-10 | President And Fellows Of Harvard College | Particle-assisted nucleic acid sequencing |
WO2010117804A2 (en) * | 2009-03-30 | 2010-10-14 | The Regents Of The University Of California | Mostly natural dna sequencing by synthesis |
US8673627B2 (en) | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
US8776573B2 (en) | 2009-05-29 | 2014-07-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US20120261274A1 (en) | 2009-05-29 | 2012-10-18 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US10385391B2 (en) | 2009-09-22 | 2019-08-20 | President And Fellows Of Harvard College | Entangled mate sequencing |
EP3842150A1 (en) | 2009-10-27 | 2021-06-30 | President and Fellows of Harvard College | Droplet creation techniques |
CN106701739A (en) | 2009-12-04 | 2017-05-24 | 株式会社日立制作所 | Analysis device and equipment for gene expression analysis |
US8603741B2 (en) | 2010-02-18 | 2013-12-10 | Pacific Biosciences Of California, Inc. | Single molecule sequencing with two distinct chemistry steps |
US9164070B2 (en) | 2010-06-30 | 2015-10-20 | Life Technologies Corporation | Column adc |
JP2013533482A (en) | 2010-06-30 | 2013-08-22 | ライフ テクノロジーズ コーポレーション | Ion-sensitive charge storage circuit and method |
US20120001646A1 (en) | 2010-06-30 | 2012-01-05 | Life Technologies Corporation | Methods and apparatus for testing isfet arrays |
US11307166B2 (en) | 2010-07-01 | 2022-04-19 | Life Technologies Corporation | Column ADC |
JP5876044B2 (en) | 2010-07-03 | 2016-03-02 | ライフ テクノロジーズ コーポレーション | Chemically sensitive sensor with lightly doped drain |
EP2617061B1 (en) | 2010-09-15 | 2021-06-30 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
CN105911126B (en) | 2010-09-24 | 2018-12-18 | 生命科技公司 | Matched transistor pair circuit |
US10392726B2 (en) | 2010-10-08 | 2019-08-27 | President And Fellows Of Harvard College | High-throughput immune sequencing |
WO2012048341A1 (en) | 2010-10-08 | 2012-04-12 | President And Fellows Of Harvard College | High-throughput single cell barcoding |
US10093981B2 (en) | 2010-10-19 | 2018-10-09 | Northwestern University | Compositions and methods for identifying depressive disorders |
US20150225792A1 (en) | 2014-01-17 | 2015-08-13 | Northwestern University | Compositions and methods for identifying depressive disorders |
US10233501B2 (en) | 2010-10-19 | 2019-03-19 | Northwestern University | Biomarkers predictive of predisposition to depression and response to treatment |
US20150218639A1 (en) | 2014-01-17 | 2015-08-06 | Northwestern University | Biomarkers predictive of predisposition to depression and response to treatment |
US9260753B2 (en) | 2011-03-24 | 2016-02-16 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
US9624539B2 (en) | 2011-05-23 | 2017-04-18 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using Raman and infrared spectroscopy detection |
EP2718465B1 (en) | 2011-06-09 | 2022-04-13 | Illumina, Inc. | Method of making an analyte array |
US9670538B2 (en) | 2011-08-05 | 2017-06-06 | Ibis Biosciences, Inc. | Nucleic acid sequencing by electrochemical detection |
EP2771103B1 (en) | 2011-10-28 | 2017-08-16 | Illumina, Inc. | Microarray fabrication system and method |
CA2854023A1 (en) | 2011-11-07 | 2013-05-16 | Illumina, Inc. | Integrated sequencing apparatuses and methods of use |
US9970984B2 (en) | 2011-12-01 | 2018-05-15 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
EP2795333A4 (en) | 2011-12-20 | 2016-02-17 | Univ Michigan | Pseudogenes and uses thereof |
WO2013096799A1 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Systems and methods for isolating nucleic acids from cellular samples |
WO2013096819A2 (en) | 2011-12-22 | 2013-06-27 | Ibis Biosciences, Inc. | Macromolecule positioning by electrical potential |
US9803188B2 (en) | 2011-12-22 | 2017-10-31 | Ibis Biosciences, Inc. | Systems and methods for isolating nucleic acids |
US9506113B2 (en) | 2011-12-28 | 2016-11-29 | Ibis Biosciences, Inc. | Nucleic acid ligation systems and methods |
WO2013102081A2 (en) | 2011-12-29 | 2013-07-04 | Ibis Biosciences, Inc. | Macromolecule delivery to nanowells |
US9222115B2 (en) | 2011-12-30 | 2015-12-29 | Abbott Molecular, Inc. | Channels with cross-sectional thermal gradients |
CA2860594A1 (en) | 2012-01-09 | 2013-07-18 | Oslo Universitetssykehus Hf | Methods and biomarkers for analysis of colorectal cancer |
CN104334739A (en) | 2012-01-13 | 2015-02-04 | Data生物有限公司 | Genotyping by next-generation sequencing |
US8821798B2 (en) | 2012-01-19 | 2014-09-02 | Life Technologies Corporation | Titanium nitride as sensing layer for microwell structure |
US8747748B2 (en) | 2012-01-19 | 2014-06-10 | Life Technologies Corporation | Chemical sensor with conductive cup-shaped sensor surface |
WO2013123125A1 (en) | 2012-02-17 | 2013-08-22 | President And Fellows Of Harvard College | Assembly of nucleic acid sequences in emulsions |
US9506117B2 (en) | 2012-02-21 | 2016-11-29 | Oslo Universitetssykehus Hf | Methods and biomarkers for detection and prognosis of cervical cancer |
IN2014DN08312A (en) | 2012-03-06 | 2015-05-15 | Univ Oslo Hf | |
US9803239B2 (en) | 2012-03-29 | 2017-10-31 | Complete Genomics, Inc. | Flow cells for high density array chips |
WO2013152114A1 (en) | 2012-04-03 | 2013-10-10 | The Regents Of The University Of Michigan | Biomarker associated with irritable bowel syndrome and crohn's disease |
ES2683707T3 (en) | 2012-05-02 | 2018-09-27 | Ibis Biosciences, Inc. | DNA sequencing |
ES2840456T3 (en) | 2012-05-02 | 2021-07-06 | Ibis Biosciences Inc | DNA sequencing |
US20150133310A1 (en) | 2012-05-02 | 2015-05-14 | Ibis Biosciences, Inc. | Nucleic acid sequencing systems and methods |
WO2013166304A1 (en) | 2012-05-02 | 2013-11-07 | Ibis Biosciences, Inc. | Dna sequencing |
US8786331B2 (en) | 2012-05-29 | 2014-07-22 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
WO2014005076A2 (en) | 2012-06-29 | 2014-01-03 | The Regents Of The University Of Michigan | Methods and biomarkers for detection of kidney disorders |
US10400280B2 (en) | 2012-08-14 | 2019-09-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
AU2013302756C1 (en) | 2012-08-14 | 2018-05-17 | 10X Genomics, Inc. | Microcapsule compositions and methods |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CN104797718B (en) * | 2012-09-12 | 2020-05-08 | 加利福尼亚大学董事会 | Accurate genome sequencing of single cells by single-stranded amplification and sequencing |
KR101595159B1 (en) * | 2012-12-07 | 2016-02-18 | 서울대학교산학협력단 | Isolation method of biochemical molecules on microarray |
EP3567116A1 (en) | 2012-12-14 | 2019-11-13 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9080968B2 (en) | 2013-01-04 | 2015-07-14 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
US9841398B2 (en) | 2013-01-08 | 2017-12-12 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
US8962366B2 (en) | 2013-01-28 | 2015-02-24 | Life Technologies Corporation | Self-aligned well structures for low-noise chemical sensors |
KR102190198B1 (en) | 2013-02-08 | 2020-12-14 | 10엑스 제노믹스, 인크. | Polynucleotide barcode generation |
US9512422B2 (en) | 2013-02-26 | 2016-12-06 | Illumina, Inc. | Gel patterned surfaces |
AU2013380645B2 (en) | 2013-03-08 | 2018-03-15 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
DK2964624T3 (en) | 2013-03-08 | 2017-04-03 | Illumina Cambridge Ltd | RHODAMINE COMPOUNDS AND USE AS FLUORESCING LABELS |
US8841217B1 (en) | 2013-03-13 | 2014-09-23 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
EP2971169A4 (en) | 2013-03-13 | 2016-10-26 | Abbott Molecular Inc | Systems and methods for isolating nucleic acids |
US8963216B2 (en) | 2013-03-13 | 2015-02-24 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
JP2016512437A (en) | 2013-03-14 | 2016-04-28 | アボツト・モレキユラー・インコーポレイテツド | Multiple methylation specific amplification systems and methods |
EP2971154A4 (en) | 2013-03-14 | 2017-03-01 | Ibis Biosciences, Inc. | Nucleic acid control panels |
WO2014149778A1 (en) | 2013-03-15 | 2014-09-25 | Life Technologies Corporation | Chemical sensors with consistent sensor surface areas |
EP3388442A1 (en) | 2013-03-15 | 2018-10-17 | Illumina Cambridge Limited | Modified nucleosides or nucleotides |
EP2971140B1 (en) | 2013-03-15 | 2019-01-16 | Ibis Biosciences, Inc. | Methods to assess contamination in dna sequencing |
US9116117B2 (en) | 2013-03-15 | 2015-08-25 | Life Technologies Corporation | Chemical sensor with sidewall sensor surface |
WO2014144883A1 (en) | 2013-03-15 | 2014-09-18 | The Trustees Of Columbia University In The City Of New York | Raman cluster tagged molecules for biological imaging |
CN105051525B (en) | 2013-03-15 | 2019-07-26 | 生命科技公司 | Chemical device with thin conducting element |
WO2014149780A1 (en) | 2013-03-15 | 2014-09-25 | Life Technologies Corporation | Chemical sensor with consistent sensor surface areas |
CN105358709B (en) | 2013-03-15 | 2018-12-07 | 雅培分子公司 | System and method for detecting genome copy numbers variation |
US9835585B2 (en) | 2013-03-15 | 2017-12-05 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
US20140336063A1 (en) | 2013-05-09 | 2014-11-13 | Life Technologies Corporation | Windowed Sequencing |
US10458942B2 (en) | 2013-06-10 | 2019-10-29 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
ES2700529T3 (en) | 2013-07-01 | 2019-02-18 | Illumina Inc | Functionalization of surface without catalyst and polymer graft |
JP6300260B2 (en) * | 2013-08-28 | 2018-03-28 | 国立大学法人埼玉大学 | Method for producing replica microarray and original microarray containing target substance produced by the method |
US10395758B2 (en) | 2013-08-30 | 2019-08-27 | 10X Genomics, Inc. | Sequencing methods |
US10294511B2 (en) | 2013-10-17 | 2019-05-21 | Illumina, Inc. | Methods and compositions for preparing nucleic acid libraries |
US20160279068A1 (en) | 2013-11-08 | 2016-09-29 | President And Fellows Of Harvard College | Microparticles, methods for their preparation and use |
CN106460032B (en) | 2013-12-05 | 2019-12-24 | 生捷科技控股公司 | Preparation of patterned arrays |
CN105940024B (en) | 2013-12-05 | 2019-03-15 | 生捷科技控股公司 | The surface of modification |
US10597715B2 (en) | 2013-12-05 | 2020-03-24 | Centrillion Technology Holdings | Methods for sequencing nucleic acids |
CA2931533C (en) | 2013-12-09 | 2023-08-08 | Illumina, Inc. | Methods and compositions for targeted nucleic acid sequencing |
WO2015089438A1 (en) | 2013-12-13 | 2015-06-18 | Northwestern University | Biomarkers for post-traumatic stress states |
US9824068B2 (en) | 2013-12-16 | 2017-11-21 | 10X Genomics, Inc. | Methods and apparatus for sorting data |
WO2015095355A2 (en) | 2013-12-17 | 2015-06-25 | The Brigham And Women's Hospital, Inc. | Detection of an antibody against a pathogen |
EP3572875A1 (en) | 2013-12-19 | 2019-11-27 | Illumina, Inc. | Roll-to-roll process of preparing a patterned substrate and patterned substrate prepared by the same process |
WO2015103225A1 (en) | 2013-12-31 | 2015-07-09 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
WO2015107430A2 (en) | 2014-01-16 | 2015-07-23 | Oslo Universitetssykehus Hf | Methods and biomarkers for detection and prognosis of cervical cancer |
US20150203907A1 (en) * | 2014-01-17 | 2015-07-23 | Florida State University Research Foundation | Genome capture and sequencing to determine genome-wide copy number variation |
US11060139B2 (en) | 2014-03-28 | 2021-07-13 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
DE202015009494U1 (en) | 2014-04-10 | 2018-02-08 | 10X Genomics, Inc. | Fluidic devices and systems for encapsulating and partitioning reagents, and their applications |
GB201408077D0 (en) | 2014-05-07 | 2014-06-18 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
EP3151733B1 (en) | 2014-06-06 | 2020-04-15 | The Regents Of The University Of Michigan | Compositions and methods for characterizing and diagnosing periodontal disease |
US11155809B2 (en) | 2014-06-24 | 2021-10-26 | Bio-Rad Laboratories, Inc. | Digital PCR barcoding |
MX2016016902A (en) | 2014-06-26 | 2017-03-27 | 10X Genomics Inc | Methods of analyzing nucleic acids from individual cells or cell populations. |
KR20170023979A (en) | 2014-06-26 | 2017-03-06 | 10엑스 제노믹스, 인크. | Processes and systems for nucleic acid sequence assembly |
CN107209188A (en) | 2014-06-27 | 2017-09-26 | 雅培制药有限公司 | Composition and method for detecting people Pegivirus 2 (HPgV 2) |
CN106715718B (en) | 2014-07-24 | 2021-07-06 | 雅培分子公司 | Compositions and methods for detecting and analyzing mycobacterium tuberculosis |
CN107002293B (en) | 2014-09-17 | 2020-12-08 | 艾比斯生物科学公司 | Sequencing by synthesis using pulsed readout optics |
CN107002128A (en) | 2014-10-29 | 2017-08-01 | 10X 基因组学有限公司 | The method and composition being sequenced for target nucleic acid |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
EP3218467A4 (en) | 2014-11-13 | 2018-04-11 | The Board of Trustees of the University of Illinois | Bio-engineered hyper-functional "super" helicases |
EP3234575B1 (en) | 2014-12-18 | 2023-01-25 | Life Technologies Corporation | Apparatus for measuring analytes using large scale fet arrays |
US10077472B2 (en) | 2014-12-18 | 2018-09-18 | Life Technologies Corporation | High data rate integrated circuit with power management |
KR102593647B1 (en) | 2014-12-18 | 2023-10-26 | 라이프 테크놀로지스 코포레이션 | High data rate integrated circuit with transmitter configuration |
SG11201705615UA (en) | 2015-01-12 | 2017-08-30 | 10X Genomics Inc | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
SG11201705425SA (en) | 2015-01-13 | 2017-08-30 | 10X Genomics Inc | Systems and methods for visualizing structural variation and phasing information |
MX2017010142A (en) | 2015-02-09 | 2017-12-11 | 10X Genomics Inc | Systems and methods for determining structural variation and phasing using variant call data. |
US10208339B2 (en) | 2015-02-19 | 2019-02-19 | Takara Bio Usa, Inc. | Systems and methods for whole genome amplification |
CN107407685B (en) | 2015-02-20 | 2021-08-03 | 宝生物工程(美国)有限公司 | Method for rapid and accurate dispensing, visualization and analysis of individual cells |
EP3262407B1 (en) | 2015-02-24 | 2023-08-30 | 10X Genomics, Inc. | Partition processing methods and systems |
AU2016222719B2 (en) | 2015-02-24 | 2022-03-31 | 10X Genomics, Inc. | Methods for targeted nucleic acid sequence coverage |
GB201508858D0 (en) | 2015-05-22 | 2015-07-01 | Illumina Cambridge Ltd | Polymethine compounds with long stokes shifts and their use as fluorescent labels |
WO2016201111A1 (en) * | 2015-06-09 | 2016-12-15 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
CA2992449A1 (en) | 2015-07-14 | 2017-01-19 | Abbott Molecular Inc. | Purification of nucleic acids using copper-titanium oxides |
US10526664B2 (en) | 2015-07-14 | 2020-01-07 | Abbott Molecular Inc. | Compositions and methods for identifying drug resistant tuberculosis |
CN107835857A (en) | 2015-07-17 | 2018-03-23 | 亿明达股份有限公司 | For the polymer sheet layer of application to be sequenced |
RU2018105835A (en) | 2015-07-17 | 2019-08-19 | Президент Энд Фэллоуз Оф Харвард Коллидж | METHODS OF AMPLIFICATION OF NUCLEIC ACID SEQUENCES |
GB201516987D0 (en) | 2015-09-25 | 2015-11-11 | Illumina Cambridge Ltd | Polymethine compounds and their use as fluorescent labels |
EP3356381A4 (en) | 2015-09-28 | 2019-06-12 | The Trustees of Columbia University in the City of New York | Design and synthesis of novel disulfide linker based nucleotides as reversible terminators for dna sequencing by synthesis |
CN108289797B (en) | 2015-10-13 | 2022-01-28 | 哈佛学院院长及董事 | Systems and methods for making and using gel microspheres |
US11207393B2 (en) | 2015-10-16 | 2021-12-28 | President And Fellows Of Harvard College | Regulatory T cell PD-1 modulation for regulating T cell effector immune responses |
DK3882357T3 (en) | 2015-12-04 | 2022-08-29 | 10X Genomics Inc | Methods and compositions for the analysis of nucleic acids |
EP3400298B1 (en) | 2016-01-08 | 2024-03-06 | Bio-Rad Laboratories, Inc. | Multiple beads per droplet resolution |
US10626390B2 (en) | 2016-02-08 | 2020-04-21 | RGENE, Inc. | Multiple ligase compositions, systems, and methods |
JP6735348B2 (en) | 2016-02-11 | 2020-08-05 | 10エックス ジェノミクス, インコーポレイテッド | Systems, methods and media for de novo assembly of whole genome sequence data |
US20190062827A1 (en) | 2016-03-14 | 2019-02-28 | RGENE, Inc. | HYPER-THERMOSTABLE LYSINE-MUTANT ssDNA/RNA LIGASES |
US20210309965A1 (en) | 2016-03-21 | 2021-10-07 | Dana-Farber Cancer Institute, Inc. | T-cell exhaustion state-specific gene expression regulators and uses thereof |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
WO2017201302A1 (en) | 2016-05-18 | 2017-11-23 | The University Of Chicago | Btk mutation and ibrutinib resistance |
CN109313396B (en) | 2016-05-18 | 2022-11-22 | Illumina公司 | Self-assembly patterning using patterned hydrophobic surfaces |
US11091795B2 (en) | 2016-07-11 | 2021-08-17 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for diagnosing and treating arrhythmias |
JP7075394B2 (en) | 2016-07-21 | 2022-05-25 | タカラ バイオ ユーエスエー, インコーポレイテッド | Multi-Z imaging and dispensing using a multi-well device |
US10385214B2 (en) | 2016-09-30 | 2019-08-20 | Illumina Cambridge Limited | Fluorescent dyes and their uses as biomarkers |
US11530352B2 (en) | 2016-10-03 | 2022-12-20 | Illumina, Inc. | Fluorescent detection of amines and hydrazines and assaying methods thereof |
WO2018118971A1 (en) | 2016-12-19 | 2018-06-28 | Bio-Rad Laboratories, Inc. | Droplet tagging contiguity preserved tagmented dna |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CA3025880C (en) | 2016-12-22 | 2020-01-28 | Illumina Cambridge Limited | Coumarin compounds and their uses as fluorescent labels |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
EP4029939B1 (en) | 2017-01-30 | 2023-06-28 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
WO2018165207A1 (en) | 2017-03-06 | 2018-09-13 | Singular Genomic Systems, Inc. | Nucleic acid sequencing-by-synthesis (sbs) methods that combine sbs cycle steps |
WO2018175399A1 (en) | 2017-03-24 | 2018-09-27 | Bio-Rad Laboratories, Inc. | Universal hairpin primers |
CN106987645A (en) * | 2017-05-05 | 2017-07-28 | 武汉爱基百客生物科技有限公司 | A kind of apparent omics technology |
CN110870018A (en) | 2017-05-19 | 2020-03-06 | 10X基因组学有限公司 | System and method for analyzing a data set |
CN109526228B (en) | 2017-05-26 | 2022-11-25 | 10X基因组学有限公司 | Single cell analysis of transposase accessible chromatin |
US10844372B2 (en) | 2017-05-26 | 2020-11-24 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
EP3634992B1 (en) | 2017-06-08 | 2024-03-27 | The Brigham And Women's Hospital, Inc. | Methods and compositions for identifying epitopes |
US11186862B2 (en) | 2017-06-20 | 2021-11-30 | Bio-Rad Laboratories, Inc. | MDA using bead oligonucleotide |
GB201711219D0 (en) | 2017-07-12 | 2017-08-23 | Illumina Cambridge Ltd | Short pendant arm linkers for nucleotides in sequencing applications |
WO2019035955A1 (en) * | 2017-08-15 | 2019-02-21 | President And Fellows Of Harvard College | High-throughput system using a cell-free expression system and in situ sequencing |
AU2018346765A1 (en) | 2017-10-06 | 2020-04-16 | Oncotherapy Science, Inc. | Screening of T lymphocytes for cancer-specific antigens |
GB201716931D0 (en) | 2017-10-16 | 2017-11-29 | Illumina Cambridge Ltd | New fluorescent compounds and their use as biomarkers |
CN111295443B (en) | 2017-11-02 | 2024-04-16 | 生物辐射实验室股份有限公司 | Transposase-based genomic analysis |
EP3625361A1 (en) | 2017-11-15 | 2020-03-25 | 10X Genomics, Inc. | Functionalized gel beads |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
CA3083183A1 (en) | 2017-11-22 | 2019-05-31 | The Regents Of The University Of Michigan | Compositions and methods for treating cancer |
US20200347445A1 (en) * | 2017-12-28 | 2020-11-05 | Ador Diagnostics S.R.L | Method of rapidly detecting the presence of nucleic acid target molecules |
JP2021509024A (en) | 2018-01-02 | 2021-03-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Capturing a large number of droplets |
KR102653725B1 (en) | 2018-01-29 | 2024-04-01 | 세인트 쥬드 칠드런즈 리써치 호스피탈, 인코포레이티드 | Methods for Nucleic Acid Amplification |
EP3746552B1 (en) | 2018-01-31 | 2023-12-27 | Bio-Rad Laboratories, Inc. | Methods and compositions for deconvoluting partition barcodes |
WO2019191122A1 (en) | 2018-03-26 | 2019-10-03 | Qiagen Sciences, Llc | Integrative dna and rna library preparations and uses thereof |
EP3775271A1 (en) | 2018-04-06 | 2021-02-17 | 10X Genomics, Inc. | Systems and methods for quality control in single cell processing |
US20210239700A1 (en) | 2018-05-04 | 2021-08-05 | Abbott Laboratories | Hbv diagnostic, prognostic, and therapeutic methods and products |
CN112770776A (en) | 2018-07-30 | 2021-05-07 | 瑞德库尔有限责任公司 | Method and system for sample processing or analysis |
US11479816B2 (en) | 2018-08-20 | 2022-10-25 | Bio-Rad Laboratories, Inc. | Nucleotide sequence generation by barcode bead-colocalization in partitions |
WO2020086834A1 (en) | 2018-10-25 | 2020-04-30 | Singular Genomics Systems, Inc. | Nucleotide analogues |
US11293061B2 (en) | 2018-12-26 | 2022-04-05 | Illumina Cambridge Limited | Sequencing methods using nucleotides with 3′ AOM blocking group |
US20220081714A1 (en) | 2019-01-04 | 2022-03-17 | Northwestern University | Storing temporal data into dna |
US10822653B1 (en) | 2019-01-08 | 2020-11-03 | Singular Genomics Systems, Inc. | Nucleotide cleavable linkers and uses thereof |
CA3130693A1 (en) | 2019-02-19 | 2020-08-27 | Ultima Genomics, Inc. | Linkers and methods for optical detection and sequencing |
CA3103900A1 (en) | 2019-03-01 | 2020-09-10 | Illumina Cambridge Limited | Exocyclic amine substituted coumarin compounds and their uses as fluorescent labels |
WO2020178231A1 (en) | 2019-03-01 | 2020-09-10 | Illumina, Inc. | Multiplexed fluorescent detection of analytes |
NL2023327B1 (en) | 2019-03-01 | 2020-09-17 | Illumina Inc | Multiplexed fluorescent detection of analytes |
BR112020026669A2 (en) | 2019-03-01 | 2021-09-08 | Illumina Cambridge Limited | COUMARIN COMPOUND SUBSTITUTED WITH TERTIARY AMINE, NUCLEOTIDES OR OLIGONUCLEOTIDES, KIT, USE THEREOF, SEQUENCING METHOD AND METHOD TO SYNTHESIS A COMPOUND |
US11421271B2 (en) | 2019-03-28 | 2022-08-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing using photoswitchable labels |
CN114829369A (en) | 2019-11-27 | 2022-07-29 | 伊鲁米纳剑桥有限公司 | Dyes and compositions containing cyclooctatetraene |
WO2021152586A1 (en) | 2020-01-30 | 2021-08-05 | Yeda Research And Development Co. Ltd. | Methods of analyzing microbiome, immunoglobulin profile and physiological state |
EP3859012A1 (en) | 2020-02-03 | 2021-08-04 | Albert-Ludwigs-Universität Freiburg | Methods for amplification of genomic dna and preparation of sequencing libraries |
IL294909A (en) | 2020-02-13 | 2022-09-01 | Zymergen Inc | Metagenomic library and natural product discovery platform |
US11807851B1 (en) | 2020-02-18 | 2023-11-07 | Ultima Genomics, Inc. | Modified polynucleotides and uses thereof |
WO2021214766A1 (en) | 2020-04-21 | 2021-10-28 | Yeda Research And Development Co. Ltd. | Methods of diagnosing viral infections and vaccines thereto |
WO2021224677A1 (en) | 2020-05-05 | 2021-11-11 | Akershus Universitetssykehus Hf | Compositions and methods for characterizing bowel cancer |
AU2021281702A1 (en) | 2020-05-27 | 2023-01-05 | Genetic Technologies Limited | Methods of assessing risk of developing a severe response to Coronavirus infection |
CN115867560A (en) | 2020-06-22 | 2023-03-28 | 伊鲁米纳剑桥有限公司 | Nucleosides and nucleotides having 3' acetal capping groups |
US20220033900A1 (en) | 2020-07-28 | 2022-02-03 | Illumina Cambridge Limited | Substituted coumarin dyes and uses as fluorescent labels |
US20220195516A1 (en) | 2020-12-17 | 2022-06-23 | Illumina Cambridge Limited | Methods, systems and compositions for nucleic acid sequencing |
US20220195518A1 (en) | 2020-12-22 | 2022-06-23 | Illumina Cambridge Limited | Methods and compositions for nucleic acid sequencing |
US20240043915A1 (en) | 2021-02-13 | 2024-02-08 | The General Hospital Corporation | Methods and compositions for in situ macromolecule detection and uses thereof |
AU2022269804A1 (en) | 2021-05-05 | 2023-11-02 | Illumina Cambridge Limited | Fluorescent dyes containing bis-boron fused heterocycles and uses in sequencing |
US20220396832A1 (en) | 2021-05-20 | 2022-12-15 | Illumina Cambridge Limited | Compositions and methods for sequencing by synthesis |
CN117813390A (en) | 2021-12-16 | 2024-04-02 | 因美纳有限公司 | Method for metal directed cleavage of surface-bound polynucleotides |
WO2023122491A1 (en) | 2021-12-20 | 2023-06-29 | Illumina Cambridge Limited | Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides |
CN117813399A (en) | 2021-12-20 | 2024-04-02 | 因美纳有限公司 | Periodate compositions and methods for chemically cleaving surface-bound polynucleotides |
FR3130844A1 (en) | 2021-12-22 | 2023-06-23 | Bforcure | COMPOSITION AND METHOD FOR AMPLIFICATION OF NUCLEIC ACID SEQUENCES |
WO2023135485A1 (en) | 2022-01-13 | 2023-07-20 | Oslo Universitetssykehus Hf | Prostate cancer markers and uses thereof |
WO2023152568A2 (en) | 2022-02-10 | 2023-08-17 | Oslo Universitetssykehus Hf | Compositions and methods for characterizing lung cancer |
CA3223115A1 (en) | 2022-03-28 | 2023-10-05 | Xiaolin Wu | Labeled avidin and methods for sequencing |
US20230314322A1 (en) | 2022-03-29 | 2023-10-05 | Illumina, Inc. | Systems and methods of sequencing polynucleotides |
US20230313294A1 (en) | 2022-03-30 | 2023-10-05 | Illumina Cambridge Limited | Methods for chemical cleavage of surface-bound polynucleotides |
US20230332197A1 (en) | 2022-03-31 | 2023-10-19 | Illumina Singapore Pte. Ltd. | Nucleosides and nucleotides with 3' vinyl blocking group |
US20230357845A1 (en) | 2022-03-31 | 2023-11-09 | Illumina, Inc. | Compositions and methods for improving sequencing signals |
US20230383342A1 (en) | 2022-05-31 | 2023-11-30 | Illumina Cambridge Limited | Compositions and methods for nucleic acid sequencing |
US20230416279A1 (en) | 2022-06-28 | 2023-12-28 | Illumina Cambridge Limited | Fluorescent dyes containing fused tetracyclic bis-boron heterocycle and uses in sequencing |
WO2024015766A1 (en) | 2022-07-12 | 2024-01-18 | Topogene Inc. | Scalable, submicron-resolution replication of dna arrays |
WO2024039516A1 (en) | 2022-08-19 | 2024-02-22 | Illumina, Inc. | Third dna base pair site-specific dna detection |
WO2024068889A2 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Compositions and methods for reducing photo damage during sequencing |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4591567A (en) | 1982-04-21 | 1986-05-27 | California Institute Of Technology | Recombinant DNA screening system including fixed array replicator and support |
FI71768C (en) | 1984-02-17 | 1987-02-09 | Orion Yhtymae Oy | Enhanced nucleic acid reagents and process for their preparation. |
US4863849A (en) | 1985-07-18 | 1989-09-05 | New York Medical College | Automatable process for sequencing nucleotide |
US4981783A (en) | 1986-04-16 | 1991-01-01 | Montefiore Medical Center | Method for detecting pathological conditions |
SE8801070D0 (en) | 1988-03-23 | 1988-03-23 | Pharmacia Ab | METHOD FOR IMMOBILIZING A DNA SEQUENCE ON A SOLID SUPPORT |
US5188963A (en) | 1989-11-17 | 1993-02-23 | Gene Tec Corporation | Device for processing biological specimens for analysis of nucleic acids |
US5382511A (en) | 1988-08-02 | 1995-01-17 | Gene Tec Corporation | Method for studying nucleic acids within immobilized specimens |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5302509A (en) | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
US5449603A (en) * | 1989-10-24 | 1995-09-12 | Stratagene | Method for hybridizing nucleic acids using single-stranded nucleic acid binding protein |
CA2031659A1 (en) | 1990-01-26 | 1991-07-27 | John B. Findlay | Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and purification methods |
US5506350A (en) | 1990-09-20 | 1996-04-09 | Bittner; Michael L. | Production of chromosome region specific DNA sequences and transamination |
RU1794088C (en) | 1991-03-18 | 1993-02-07 | Институт Молекулярной Биологии Ан@ Ссср | Method of dna nucleotide sequence determination and a device for its realization |
US5426180A (en) | 1991-03-27 | 1995-06-20 | Research Corporation Technologies, Inc. | Methods of making single-stranded circular oligonucleotides |
DK0593618T3 (en) | 1991-06-27 | 1998-11-23 | Genelabs Tech Inc | Screening assay for detection of DNA-binding molecules |
US5578444A (en) | 1991-06-27 | 1996-11-26 | Genelabs Technologies, Inc. | Sequence-directed DNA-binding molecules compositions and methods |
US5437976A (en) | 1991-08-08 | 1995-08-01 | Arizona Board Of Regents, The University Of Arizona | Multi-domain DNA ligands bound to a solid matrix for protein and nucleic acid affinity chromatography and processing of solid-phase DNA |
WO1993009250A1 (en) * | 1991-11-01 | 1993-05-13 | Adelaide Children's Hospital | Solid phase amplification process |
US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
US5324633A (en) | 1991-11-22 | 1994-06-28 | Affymax Technologies N.V. | Method and apparatus for measuring binding affinity |
EP0672177B1 (en) * | 1992-01-28 | 2006-07-19 | President And Fellows of Harvard College | Method for nucleic acid hybridization using single-stranded dna binding protein |
EP1382386A3 (en) | 1992-02-19 | 2004-12-01 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
US5587128A (en) | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
RU2048522C1 (en) | 1992-10-14 | 1995-11-20 | Институт белка РАН | Method of nucleic acid copying, method of their expression and a medium for their realization |
US5503980A (en) | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
US5795714A (en) | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
US5658751A (en) * | 1993-04-13 | 1997-08-19 | Molecular Probes, Inc. | Substituted unsymmetrical cyanine dyes with selected permeability |
US5484702A (en) | 1994-01-27 | 1996-01-16 | Research Foundation Of The State University Of New York At Buffalo | Method for preselecting recombinant clones containing a specific nucleic acid sequence and subsequent transformation with preselected clones |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5571639A (en) | 1994-05-24 | 1996-11-05 | Affymax Technologies N.V. | Computer-aided engineering system for design of sequence arrays and lithographic masks |
US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
FR2726286B1 (en) * | 1994-10-28 | 1997-01-17 | Genset Sa | SOLID PHASE NUCLEIC ACID AMPLIFICATION PROCESS AND REAGENT KIT USEFUL FOR CARRYING OUT SAID PROCESS |
US5599695A (en) | 1995-02-27 | 1997-02-04 | Affymetrix, Inc. | Printing molecular library arrays using deprotection agents solely in the vapor phase |
US5908926A (en) | 1995-03-16 | 1999-06-01 | Duke University | 5'to 3' nucleic acid synthesis using 3'-photoremovable protecting group |
US5753439A (en) | 1995-05-19 | 1998-05-19 | Trustees Of Boston University | Nucleic acid detection methods |
US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
GB9517914D0 (en) | 1995-09-02 | 1995-11-01 | Tepnel Medical Ltd | Identification of bases in nucleic acid sequences |
EP1249705A3 (en) | 1996-12-31 | 2003-11-05 | Genometrix Genomics Incorporated | Multiplexed molecular analysis apparatus and its fabrication method |
EP3034626A1 (en) | 1997-04-01 | 2016-06-22 | Illumina Cambridge Limited | Method of nucleic acid sequencing |
AU6846798A (en) | 1997-04-01 | 1998-10-22 | Glaxo Group Limited | Method of nucleic acid sequencing |
JP4313861B2 (en) | 1997-08-01 | 2009-08-12 | キヤノン株式会社 | Manufacturing method of probe array |
US6232103B1 (en) * | 1998-03-23 | 2001-05-15 | Invitrogen Corporation | Methods useful for nucleic acid sequencing using modified nucleotides comprising phenylboronic acid |
-
1999
- 1999-03-12 US US09/267,496 patent/US6485944B1/en not_active Expired - Lifetime
-
2000
- 2000-03-10 EP EP00917853A patent/EP1235929A2/en not_active Withdrawn
- 2000-03-10 CA CA002582809A patent/CA2582809A1/en not_active Abandoned
- 2000-03-10 CA CA002370535A patent/CA2370535C/en not_active Expired - Lifetime
- 2000-03-10 WO PCT/US2000/006390 patent/WO2000053812A2/en active Search and Examination
- 2000-03-10 EP EP02079758A patent/EP1291354A3/en not_active Withdrawn
- 2000-03-10 AU AU38761/00A patent/AU3876100A/en not_active Abandoned
- 2000-03-10 CA CA002411514A patent/CA2411514A1/en not_active Abandoned
- 2000-03-10 JP JP2000603433A patent/JP2003526331A/en active Pending
- 2000-05-17 US US09/572,365 patent/US20020120126A1/en not_active Abandoned
- 2000-05-17 US US09/572,368 patent/US20020120127A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1235929A2 (en) | 2002-09-04 |
US6485944B1 (en) | 2002-11-26 |
JP2003526331A (en) | 2003-09-09 |
US20020120126A1 (en) | 2002-08-29 |
AU3876100A (en) | 2000-09-28 |
CA2370535A1 (en) | 2000-09-14 |
CA2411514A1 (en) | 2000-09-14 |
CA2370535C (en) | 2008-05-13 |
WO2000053812A3 (en) | 2002-07-11 |
EP1291354A2 (en) | 2003-03-12 |
WO2000053812A2 (en) | 2000-09-14 |
EP1291354A3 (en) | 2003-12-10 |
US20020120127A1 (en) | 2002-08-29 |
WO2000053812A9 (en) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2582809A1 (en) | Replica amplification of nucleic acid arrays | |
US20080269068A1 (en) | Multiplex decoding of sequence tags in barcodes | |
CA2239287C (en) | A cascade nucleic acid amplification reaction | |
US6221603B1 (en) | Rolling circle amplification assay for nucleic acid analysis | |
US10233443B2 (en) | Reducing adapter dimer formation | |
US7414115B2 (en) | Length determination of nucleic acid repeat sequences by discontinuous primer extension | |
EA012525B1 (en) | Method for preparing polynucleotides for analysis | |
US8202691B2 (en) | Uniform fragmentation of DNA using binding proteins | |
JP2002532104A5 (en) | ||
CA2719747A1 (en) | Compositions and methods for nucleic acid sequencing | |
EP0640146A1 (en) | Dna sequencing method. | |
JPH11510709A (en) | Optimal fluorescent oligonucleotide | |
WO2007019422A2 (en) | Signal pattern compositions and methods | |
CA2513626A1 (en) | Nucleic acid amplification using non-standard bases | |
CN110869515A (en) | Sequencing method for genome rearrangement detection | |
AU2006219698A1 (en) | Method for improving the characterisation of a polynucleotide sequence | |
WO2004015137A1 (en) | Method for comparing gene expression level | |
EP1913159B1 (en) | Detection method for gene expression | |
US20070254280A1 (en) | Method of Identifying Characteristic of Molecules | |
AU2022421156A1 (en) | Periodate compositions and methods for chemical cleavage of surface-bound polynucleotides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |